CB-86
Pharmaceutical compound
From Wikipedia, the free encyclopedia
CB-86 is a synthetic cannabinoid drug which was developed as a hybrid between classical/nonclassical cannabinoids such as THC and CP 47,497 with endogenous cannabinoid ligands such as anandamide. It acts as a partial agonist at CB1 receptors with a Ki of 5.6 nM, and an antagonist of CB2 receptors with a Ki of 7.9 nM. It has analgesic effects in studies on mice.[1]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C26H43NO3 |
| Molar mass | 417.634 g·mol−1 |
| 3D model (JSmol) | |
| |
| |